Sunday May 11th
18:00
Welcome function/Cocktails
Monday May 12th
08:00
Plenary Session
Main auditorium
Keynote Addresses
08:00
Welcome
Welcome, Gabriele Teichmann, Hannover Re (DE)
08:10
Keynote Address 1
The Future of Long Lives, David Sinclair, International Longevity Centre (UK)
09:00
Keynote Address 2
Geroscience and Implications for Ageing and Longevity, S. Jay Olshansky, University of Illinois, Chicago (US)
09:50
Break
10:10
Plenary Session
Main auditorium
Ageing
10:10
Panel Discussion 1
Ageing, Anti-ageing and Implications on the Insurance Industry, Panel Chair: Daniel Zimmerman; RGA (US); David Sinclair, International Longevity Centre (UK); S. Jay Olshansky, University of Illinois - Chicago (US); John Schoonbee, Swiss Re (CH) and Charles Bark, HiNounou (FR)
11:00
Coffee break - Exhibition Area
11:30
Plenary Session
Main auditorium
Cancer 1
11:30
Presentation 1
Updates on Breast Cancer, Miguel Barbosa, Centro Hospitalar Universitário São João, Porto (PT)
12:15
Presentation 2
Behavioural Evolution: Navigating Cancer and Insurance Implications with ICD-O Revisions, Adela Osman, RGA (ZA)
13:00
Lunch
13:10
Bonus Session
Large Meeting Room
Better care, Better Ageing, Charles Bark, HiNounou (FR)
14:00
Parallel Breakout Sessions
Main auditorium and breakout rooms
14:00
Breakout 1
Challenges in Juvenile Insurance, Michael Lo, Hannover Re (HK)
14:00
Breakout 2
The Future of Health Insurance - AI and Digital Platforms - Still Need the Human Touch!, Bill Bossany, Bossany Consulting International (US)
14:00
Breakout 3
Tuition in Insurance, Social Medicine in the EU, Loana Soare, University of Bucharest (RO)
14:50
Breakout 4
Watch the Count: Haematological Case Studies, Sheetal Salgaonkar, RGA (IN)
14:50
Breakout 5
Mortality improvements China, Ning Qing, Gen Re (CN)
14:50
Breakout 6
Critical Illness: Protection gap and Product Simplification, Matthew Procter, Hannover Re (ZA)
15:30
Coffee break - Exhibition Area
16:00
Plenary Session
Main auditorium
Cancer 2
16:00
Presentation 3
Common Cancers at Uncommon Age: What is Early-onset Cancer?, Tobias Schiergens, Swiss Re (DE)
16:45
Presentation 4
Personalised Therapies in Cancer, Eric Raymond, Paris Saint-Joseph Hospital Group (FR)
17:30
End of session
18:30
Free night
Tuesday May 13th
08:00
Plenary Session
Main auditorium
Blood screening
08:00
Presentation
Large Population Based Screening, TBC, Nightingale Health (FI)
09:00
Presentation 5
Evolving Perspective on Neurodivergence – are ADHD and Autism still a Risk to Consider in Underwriting?, Karsten Filzmaier, we4impact (DE)
09:00
Plenary Session
Main auditorium
Mental health
09:45
Plenary Session
Main auditorium
Behavioural science
09:45
Presentation 6
What Works and What Doesn't: Counter-intuitive Findings from 10 years of Applying Behavioural Science in Insurance, Will Trump, Unconventional Wisdom (UK)
10:30
Coffee break - Exhibition Area
11:00
Plenary Session
Main auditorium
Law and regulation
11:00
Panel Discussion 2
The Right to be Forgotten, Panel Chair: Fabrice Chouty, ICLAM Board Member; Alban Senn, Munich Re (DE); Gavin Magquire, SCOR (UK) and John Turner, Swiss Re (CH)
12:00
End of session
12:00
Lunch and Congress tours
19:30
Gala dinner
Wednesday May 14th
08:00
Plenary Session
Main auditorium
Blood Artificial Intelligence, Data Analytics
08:00
Presentation 7
Large Population Based Screening, Blood Screening, TBC, Nightingale Health (FI)
08:00
Presentation 8
Artificial Overview, Paulo Pinho, PASE Advisor Group (US)
09:00
Plenary Session
Main auditorium
Mental health
09:00
Presentation 9
Artificial Intelligence to Unlock the Secrets of the Heart, Emoke Posan, Partner Re (CA)
09:45
Presentation 10
How Artificial Intelligence is Being Deployed and Impacting Clinical Care, Craig Rhodes, deepC (DE)
10:30
Coffee break - Exhibition Area
11:00
Plenary Session
Main auditorium
Obesity treatments
11:00
Presentation 11
Is Insurance Coverage for Metabolic Surgery a Loss or a Gain?, Daniel Tong, Hong Kong Sanatorium & Hospital (HK)
11:45
Presentation 12
Weight Loss Without Exercise? What Are The Facts About Anti-obesity Medication and Vaccination?, David Lu, Swiss Re (HK)
12:30
Lunch
12:40
Bonus Session
Large Meeting Room
Addiction to Disability: Exploring Health Impacts and Risks, Ana Margarida Romao Franco, Addiction Department Coordinator, Hospital Lusíadas Monsanto, Lisbon (PT)
13:30
Plenary Session
Main auditorium
Infectious diseases
13:30
Presentation 13
Infectious Disease Trends: Emerging Risks and the Revolution of Vaccine Technologies, Michael Osterholm, Center for Infectious Disease Research and Policy, University of Minnesota (US)
14:15
Presentation 14
Long COVID, Tim Meagher, Munich Re (CA)
15:30
Plenary Session
Main auditorium
Gastrointestinal disease
15:00
Coffee break - Exhibition Area
15:30
Presentation 15
'Go with Your Gut’ – The Role of Microbiome in the Development of Cancer and Neurodegenerative Diseases, Sandra Mitic, Gen Re (DE)
16:15
Presentation 16
Cocktails and Covid 19 Pounds: The Essential Ingredients for Early Liver Cirrhosis, Elyssa Del Valle, Swiss Re (US)
17:00
Plenary Session
Main auditorium
Closing
17:00
Closing
Closing Remarks / Gabriele Teichmann, Hannover Re (DE)
17:15
End of session
Necesitamos su consentimiento para cargar las traducciones
Utilizamos un servicio de terceros para traducir el contenido del sitio web que puede recopilar datos sobre su actividad. Por favor revise los detalles en la política de privacidad y acepte el servicio para ver las traducciones.